Laura Malagon of GRAM talks differentiators, competencies, and prioritizing quality with Contract Pharma
In the video featuring Laura Malagon, VP of Quality and Regulatory, she discusses how Contract Development and Manufacturing Organizations (CDMOs) can evolve to meet the changing demands of the industry. Malagon emphasizes that today’s market requires CDMOs to be more than just manufacturing facilities; they should act as partners, providing comprehensive solutions from development to commercial launch. Key differentiators for CDMOs include focusing on specific areas of expertise and being innovative while prioritizing quality and speed.
Key points include the importance of having specific areas of expertise, robust quality management systems, and flexible capacity solutions to meet client needs. Malagon highlights the necessity for CDMOs to differentiate themselves through high-quality client services and accessibility to leadership. Additionally, she stresses the need for CDMOs to enhance their regulatory understanding and embrace digitalization to navigate market challenges effectively. Customized solutions tailored to each client’s requirements are also critical for building trust and delivering quality services. Overall, the discussion underscores the importance of agility and a strong focus on core competencies for CDMOs to advance in a competitive landscape.
Hear from Laura Malagon, VP of Quality and Regulatory, about advancing as a CDMO to support evolving needs in this quick video with Contract Pharma.